Svennilson Peter Insider Trading
Get the latest insider transactions of Svennilson Peter. Svennilson Peter is 10% Owner in NGM BIOPHARMACEUTICALS INC ($NGM) and Director in NGM BIOPHARMACEUTICALS INC ($NGM) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in Immune Design Corp. ($IMDZ) and in RAPT Therapeutics, Inc. ($RAPT) and Director in RAPT Therapeutics, Inc. ($RAPT) and Director in Revolution Medicines, Inc. ($RVMD) and Director in Gritstone Oncology, Inc. ($GRTS) and Director in Oric Pharmaceuticals, Inc. ($ORIC). Discover the current value of Svennilson Peter shares.
Address: C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E., SUITE 310 SEATTLE 98102WA
Svennilson Peter is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
IMDZ | IMMUNE DESIGN CORP. | Director | 2,681,000 | 14,209,300.00 |
CNST | CONSTELLATION PHARMACEUTICALS INC | Director | 4,677,939 | |
GRTS | Gritstone bio, Inc. | Director | 3,102,934 | |
NGM | NGM BIOPHARMACEUTICALS INC | 10% Owner, Director | 17,706,978 | |
ORIC | Oric Pharmaceuticals, Inc. | Director | 3,575,000 | |
RVMD | Revolution Medicines, Inc. | Director | 1,582,965 | |
RAPT | RAPT Therapeutics, Inc. | 3,835,679 |
Insider Trading Transactions of Svennilson Peter
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 24 2021 | RAPT | RAPT Therapeutics, Inc. | Svennilson Peter | Option Exercise | 19.30 | 7,500 | 144,750 | 7,500 | |
Jun 17 2021 | ORIC | Oric Pharmaceuticals, Inc ... | Svennilson Peter | Director | Option Exercise | 19.03 | 16,625 | 316,374 | 16,625 |
Apr 28 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 42.85 | 24,883 | 1,066,147 | 1,582,965 |
Apr 28 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 42.85 | 28,101 | 1,204,027 | 1,787,660 |
Apr 28 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 42.65 | 10,955 | 467,263 | 1,572,010 |
Apr 28 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 42.65 | 12,371 | 527,659 | 1,775,289 |
Apr 28 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 42.50 | 47 | 1,998 | 1,571,963 |
Apr 28 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 42.50 | 53 | 2,253 | 1,775,236 |
Apr 12 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 44.80 | 21,710 | 972,697 | 1,619,448 |
Apr 12 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 44.80 | 24,518 | 1,098,507 | 1,828,862 |
Apr 12 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 43.83 | 11,600 | 508,379 | 1,607,848 |
Apr 12 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 43.83 | 13,101 | 574,162 | 1,815,761 |
Apr 07 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 46.65 | 8,554 | 399,085 | 1,672,837 |
Apr 07 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 46.65 | 9,661 | 450,732 | 1,889,154 |
Apr 07 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 48.06 | 18,551 | 891,594 | 1,654,286 |
Apr 07 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 48.06 | 20,949 | 1,006,847 | 1,868,205 |
Apr 07 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 45.60 | 13,128 | 598,696 | 1,641,158 |
Apr 07 2021 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 45.60 | 14,825 | 676,087 | 1,853,380 |
Apr 02 2021 | RAPT | RAPT Therapeutics, Inc. | Svennilson Peter | Option Exercise | 22.20 | 2,229 | 49,484 | 2,229 | |
Dec 11 2020 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 0.00 | 469,635 | 0 | 1,681,391 |
Dec 11 2020 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Buy | 0.00 | 22,011 | 0 | 22,011 |
Dec 11 2020 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 0.00 | 530,365 | 0 | 1,898,815 |
Dec 11 2020 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Buy | 0.00 | 24,857 | 0 | 46,868 |
Dec 11 2020 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Sell | 0.00 | 46,868 | 0 | 0 |
Dec 11 2020 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Buy | 0.00 | 46 | 0 | 46 |
Dec 11 2020 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Buy | 0.00 | 13,068 | 0 | 20,302 |
Sep 22 2020 | RAPT | RAPT Therapeutics, Inc. | Svennilson Peter | Director | Sell | 30.85 | 608,000 | 18,756,800 | 3,835,679 |
Aug 19 2020 | RAPT | RAPT Therapeutics, Inc. | Svennilson Peter | Director | Sell | 22.75 | 538,654 | 12,254,379 | 4,443,679 |
Jun 19 2020 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Buy | 0.00 | 7,234 | 0 | 7,234 |
Jun 19 2020 | RVMD | Revolution Medicines, Inc ... | Svennilson Peter | Director | Option Exercise | 36.57 | 25,318 | 925,879 | 25,318 |
Jun 19 2020 | RAPT | RAPT Therapeutics, Inc. | Svennilson Peter | Director | Option Exercise | 28.27 | 22,500 | 636,075 | 22,500 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | Svennilson Peter | Director | Buy | 0.00 | 3,500,000 | 0 | 3,575,000 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | Svennilson Peter | Director | Buy | 0.00 | 625,000 | 0 | 4,200,000 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | Svennilson Peter | Director | Buy | 0.00 | 416,666 | 0 | 4,616,666 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | Svennilson Peter | Director | Buy | 0.00 | 151,515 | 0 | 4,768,181 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | Svennilson Peter | Director | Option Exercise | 0.00 | 3,500,000 | 0 | 0 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | Svennilson Peter | Director | Option Exercise | 0.00 | 625,000 | 0 | 0 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | Svennilson Peter | Director | Option Exercise | 0.00 | 416,666 | 0 | 0 |
Apr 28 2020 | ORIC | Oric Pharmaceuticals, Inc ... | Svennilson Peter | Director | Option Exercise | 0.00 | 151,515 | 0 | 0 |
Apr 27 2020 | ORIC | Oric Pharmaceuticals, Inc ... | Svennilson Peter | Director | Option Exercise | 16.00 | 16,625 | 266,000 | 16,625 |
Apr 09 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 14.95 | 112,602 | 1,683,400 | 17,706,978 |
Apr 07 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 12.41 | 14,587 | 181,025 | 17,470,648 |
Apr 07 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 14.38 | 123,728 | 1,779,209 | 17,594,376 |
Apr 02 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 12.53 | 118,067 | 1,479,380 | 17,323,144 |
Apr 02 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 12.26 | 118,067 | 1,447,501 | 17,441,211 |
Apr 02 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 12.40 | 14,850 | 184,140 | 17,456,061 |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 11.63 | 170,387 | 1,981,601 | 17,074,284 |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 12.22 | 128,377 | 1,568,767 | 17,202,661 |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 12.49 | 2,416 | 30,176 | 17,205,077 |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 11.63 | 170,387 | 1,981,601 | 17,074,284 |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 12.22 | 128,377 | 1,568,767 | 17,202,661 |
Mar 25 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 12.49 | 2,416 | 30,176 | 17,205,077 |
Mar 23 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 11.59 | 148,464 | 1,720,698 | 16,760,815 |
Mar 23 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 11.77 | 143,082 | 1,684,075 | 16,903,897 |
Mar 06 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 18.00 | 8,307 | 149,526 | 16,612,351 |
Mar 04 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 17.90 | 14,124 | 252,820 | 16,555,300 |
Mar 04 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 17.99 | 38,758 | 697,256 | 16,594,058 |
Mar 04 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 17.96 | 9,986 | 179,349 | 16,604,044 |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 18.00 | 3,751 | 67,518 | 16,469,480 |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 17.91 | 33,896 | 607,077 | 16,503,376 |
Feb 28 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 17.91 | 37,800 | 676,998 | 16,541,176 |
Feb 10 2020 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 15.96 | 44,900 | 716,604 | 16,465,729 |
Nov 13 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 12.00 | 15 | 180 | 16,420,829 |
Nov 06 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 11.99 | 8,409 | 100,824 | 16,420,814 |
Oct 24 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 12.00 | 2,300 | 27,600 | 16,410,318 |
Oct 24 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 11.86 | 2,087 | 24,752 | 16,412,405 |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 10.62 | 6,818 | 72,407 | 16,329,897 |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 11.29 | 34,721 | 392,000 | 16,364,618 |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 11.94 | 43,400 | 518,196 | 16,408,018 |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 10.62 | 6,818 | 72,407 | 16,329,897 |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 11.29 | 34,721 | 392,000 | 16,364,618 |
Oct 21 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 11.94 | 43,400 | 518,196 | 16,408,018 |
Oct 16 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 10.36 | 34,900 | 361,564 | 16,254,979 |
Oct 16 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 10.31 | 33,200 | 342,292 | 16,288,179 |
Oct 16 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 10.26 | 34,900 | 358,074 | 16,323,079 |
Oct 11 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | 10% Owner | Buy | 10.26 | 17,724 | 181,848 | 16,184,631 |
Oct 11 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | 10% Owner | Buy | 10.50 | 17,724 | 186,102 | 16,202,355 |
Oct 11 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | 10% Owner | Buy | 10.57 | 17,724 | 187,343 | 16,220,079 |
Aug 09 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 14.00 | 224,500 | 3,143,000 | 16,166,743 |
Aug 09 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.98 | 12 | 168 | 16,166,755 |
Aug 09 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.99 | 152 | 2,126 | 16,166,907 |
Aug 07 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.98 | 5,824 | 81,400 | 15,941,933 |
Aug 07 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.96 | 310 | 4,328 | 15,942,243 |
Aug 05 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.98 | 2,600 | 36,346 | 15,934,327 |
Aug 05 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.97 | 1,782 | 24,898 | 15,936,109 |
Jul 31 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.58 | 19,201 | 260,727 | 15,922,872 |
Jul 31 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.91 | 8,855 | 123,195 | 15,931,727 |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.51 | 29,054 | 392,502 | 15,842,859 |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.37 | 30,753 | 411,294 | 15,873,612 |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.59 | 30,059 | 408,634 | 15,903,671 |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.51 | 29,054 | 392,502 | 15,842,859 |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.37 | 30,753 | 411,294 | 15,873,612 |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.59 | 30,059 | 408,634 | 15,903,671 |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.99 | 6,222 | 87,043 | 15,752,285 |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.54 | 30,760 | 416,337 | 15,783,045 |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.35 | 30,760 | 410,535 | 15,813,805 |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.69 | 16,188 | 221,547 | 15,742,163 |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.86 | 3,900 | 54,055 | 15,746,063 |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.87 | 10,870 | 150,752 | 15,704,961 |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.88 | 21,014 | 291,765 | 15,725,975 |
Jun 26 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.78 | 12,240 | 168,650 | 15,694,091 |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.91 | 15,214 | 211,674 | 15,662,688 |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.86 | 15,400 | 213,385 | 15,678,088 |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 14.03 | 3,763 | 52,789 | 15,681,851 |
Jun 20 2019 | GRTS | Gritstone Oncology, Inc. | Svennilson Peter | Director | Option Exercise | 10.86 | 8,570 | 93,070 | 8,570 |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 14.00 | 7,500 | 104,989 | 15,625,214 |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 14.13 | 11,500 | 162,508 | 15,636,714 |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 14.00 | 10,760 | 150,687 | 15,647,474 |
Jun 11 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.66 | 12,600 | 172,176 | 15,606,814 |
Jun 11 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.83 | 10,900 | 150,718 | 15,617,714 |
Jun 06 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.39 | 12,600 | 168,764 | 15,581,614 |
Jun 06 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.40 | 12,600 | 168,884 | 15,594,214 |
May 22 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.50 | 50,000 | 675,000 | 15,569,014 |
May 17 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Option Exercise | 13.35 | 24,000 | 320,400 | 24,000 |
May 13 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 13.85 | 17,923 | 248,234 | 15,519,014 |
May 09 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 14.10 | 57,000 | 803,700 | 15,501,091 |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 16.00 | 20,000 | 320,000 | 20,000 |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 16.00 | 1,875,000 | 30,000,000 | 2,350,957 |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Buy | 0.00 | 13,093,134 | 0 | 15,444,091 |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Option Exercise | 0.00 | 12,000,000 | 0 | 0 |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Option Exercise | 0.00 | 8,408,933 | 0 | 0 |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Option Exercise | 0.00 | 2,377,334 | 0 | 0 |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTICALS IN ... | Svennilson Peter | Director | Option Exercise | 0.00 | 3,400,000 | 0 | 0 |
Oct 02 2018 | GRTS | Gritstone Oncology, Inc. | Svennilson Peter | Director | Buy | 0.00 | 3,102,934 | 0 | 3,102,934 |
Oct 02 2018 | GRTS | Gritstone Oncology, Inc. | Svennilson Peter | Director | Option Exercise | 0.00 | 2,173,912 | 0 | 0 |
Oct 02 2018 | GRTS | Gritstone Oncology, Inc. | Svennilson Peter | Director | Option Exercise | 0.00 | 929,022 | 0 | 0 |
Jul 23 2018 | CNST | CONSTELLATION PHARMACEUTI ... | Svennilson Peter | Director | Buy | 0.00 | 4,666,888 | 0 | 4,677,939 |
Jul 23 2018 | CNST | CONSTELLATION PHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | 0.00 | 11,000,000 | 0 | 0 |
Jul 23 2018 | CNST | CONSTELLATION PHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | 0.00 | 8,333,333 | 0 | 0 |
Jul 23 2018 | CNST | CONSTELLATION PHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | 0.00 | 970,159 | 0 | 0 |
Jul 23 2018 | CNST | CONSTELLATION PHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | 0.00 | 3,555,555 | 0 | 0 |
Jul 23 2018 | CNST | CONSTELLATION PHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | 0.00 | 6,502,856 | 0 | 0 |
Jul 23 2018 | CNST | CONSTELLATION PHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | 0.00 | 20,000,000 | 0 | 0 |
Jan 08 2018 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Option Exercise | 4.05 | 12,500 | 50,625 | 12,500 |
Oct 27 2017 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Buy | 4.10 | 2,681,000 | 10,992,100 | 2,681,000 |
Jan 06 2017 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Option Exercise | 5.60 | 10,000 | 56,000 | 10,000 |
Sep 20 2016 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Buy | 6.25 | 800,000 | 5,000,000 | 800,000 |
Jan 06 2016 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Option Exercise | 19.39 | 9,300 | 180,327 | 9,300 |
Jan 09 2015 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Option Exercise | 31.00 | 9,300 | 288,300 | 9,300 |
Jul 31 2014 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Buy | 0.00 | 733,943 | 0 | 733,943 |
Jul 31 2014 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Buy | 0.00 | 744,580 | 0 | 1,478,523 |
Jul 31 2014 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Buy | 0.00 | 856,269 | 0 | 2,334,792 |
Jul 31 2014 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Buy | 0.00 | 428,134 | 0 | 2,762,926 |
Jul 31 2014 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Buy | 12.00 | 399,016 | 4,788,192 | 3,161,942 |
Jul 31 2014 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Option Exercise | 0.00 | 733,943 | 0 | 0 |
Jul 31 2014 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Option Exercise | 0.00 | 744,580 | 0 | 0 |
Jul 31 2014 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Option Exercise | 0.00 | 856,269 | 0 | 0 |
Jul 31 2014 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Option Exercise | 8.18 | 428,134 | 3,499,995 | 0 |
Jul 31 2014 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Option Exercise | 0.00 | 428,134 | 0 | 428,134 |
Jul 31 2014 | IMDZ | Immune Design Corp. | Svennilson Peter | Director | Option Exercise | 0.00 | 428,134 | 0 | 0 |